Related Experiment Video
Updated: Aug 8, 2026

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium
Guilherme H M Oliveira1, Corinne N Brann, Katy Becker
1Baylor College of Medicine, Houston, Texas; Methodist DeBakey Heart Center, Houston, Texas, USA.
Insights
The complement system
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Heart failure involves inflammatory cytokine pathways.
- The complement system, producing the membrane attack complex (MAC), is a key inflammatory response.
- MAC causes cell lysis and apoptosis.
Purpose of the Study:
- To investigate complement system activation in heart failure.
- To determine if hemodynamic conditions regulate MAC expression in the failing heart.
Main Methods:
- Assessed MAC expression in myocardial biopsies from normal and failing hearts.
- Utilized immunohistochemistry and Western blot analysis.
- Analyzed samples before and after left ventricular assist device (LVAD) implantation.
Main Results:
- Increased MAC expression was found in failing hearts, but not normal hearts.
- MAC expression decreased to normal levels after hemodynamic unloading with LVAD support.
- No difference in MAC expression was observed between ischemic and non-ischemic heart failure causes.
Conclusions:
- The complement system is activated in the heart failure environment, evidenced by increased MAC expression.
- Hemodynamic normalization dynamically regulates MAC expression, suggesting a pathogenic role.
- The complement system represents a novel therapeutic target for heart failure.
Abstract:
Inflammatory cytokine-mediated pathways are activated in heart failure and participate in the pathogenesis and progression of the disease. Another major response to inflammation is mediated through the complement system with the production of the membrane attack complex (MAC), a protein known to cause cell lysis and mediate apoptosis. It was postulated that the complement system is activated in patients with heart failure, and this study investigated whether hemodynamic conditions regulate this pathway. The expression of the MAC was assessed in myocardial biopsy samples of normal and failing hearts by immunohistochemistry and Western blot analysis. Myocardial samples from failing hearts were obtained before and after left ventricular assist device implantation. Immunohistochemical staining and Western blot analysis identified increased MAC expression in failing but not normal myocardium. After hemodynamic unloading with left ventricular assist device support, MAC expression returned to levels found in normal controls. In failing hearts, MAC expression did not differ between ischemic and nonischemic causes of heart failure. In conclusion, increased MAC expression in failing human hearts indicates that the complement system is activated in the heart failure milieu. Its removal after hemodynamic normalization is evidence of dynamic regulation, suggesting a pathogenic role for the MAC. These findings identify the complement system as part of a novel pathophysiologic path in heart failure that can potentially be targeted by future therapy.
Related Concept Videos
Myocarditis I: Introduction
Complement System
The Inner Mitochondrial Membrane
Pathophysiology of Cardiac Performance
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests

